Prev Arrow Stocks

IDEX Corporation ($IEX) Stock Forecast: Up 5.2% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is IDEX Corporation?

IDEX Corp (IEX) is a diversified manufacturing company that operates in various industrial markets, including Health & Science Technologies (HST) segment.

Why is IDEX Corporation going up?

IEX stock is up 5.2% on Feb 4, 2026 18:06

  • IDEX (IEX) experienced a strong uptrend today supported by its robust Q4 2025 performance and optimistic projections for 2026.
  • The company's success in the HST segment, fueled by demand from data centers and semiconductors, notably influenced the positive market movement.
  • Significant order increase in AI-related ventures, surpassing earnings and revenue forecasts, reinforced investor faith in IDEX.
  • Despite maintaining a Zacks Rank #4 (Sell) owing to adjustments in estimates, the favorable financial outcomes and outlook are likely to have eclipsed this, prompting the bullish market activity.

IEX Price Chart

IEX Technical Analysis

IEX News

IDEX (IEX) Q4 2025 Earnings Call Transcript

IDEX (IEX) reported solid Q4 2025 results, driven by strong performance in its Health & Science Technologies (HST) segment, particularly due to demand from data centers and semiconductors. The company achieved 1% organic revenue growth and expanded its adjusted EBITDA margin by 40 basis points. For 2026, IDEX anticipates 1%-2% organic growth, an adjusted EBITDA margin of 26%-27%, and adjusted EPS of $8.15-$8.35, while maintaining commitments to capital allocation including dividends and share repurchases.

https://www.theglobeandmail.com/investing/markets/markets-news/Motley%20Fool/23416/idex-iex-q4-2025-earnings-call-transcript/

0 News Article Image IDEX (IEX) Q4 2025 Earnings Call Transcript

IDEX Corp (NYSE:IEX) Reports In-Line Q4 Earnings, Highlights AI-Driven Order Growth Amid Mixed Segment Demand

IDEX Corp (NYSE:IEX) reported fourth-quarter 2025 earnings that largely met Wall Street expectations, with adjusted EPS of $2.10 and revenue of $899.1 million. The company experienced strong order growth in its Health & Science Technologies segment, driven by AI-related projects, but faced softer demand in other segments. Despite a subdued market reaction to its 2026 outlook for modest organic sales growth and adjusted EPS of $8.15 to $8.35, IDEX demonstrated strong cash generation and capital returns.

https://www.chartmill.com/news/IEX/Chartmill-41103-IDEX-Corp-NYSEIEX-Reports-In-Line-Q4-Earnings-Highlights-AI-Driven-Order-Growth-Amid-Mixed-Segment-Demand

1 News Article Image IDEX Corp (NYSE:IEX) Reports In-Line Q4 Earnings, Highlights AI-Driven Order Growth Amid Mixed Segment Demand

Idex (IEX) Q4 Earnings and Revenues Beat Estimates

Idex (IEX) reported strong Q4 results, with earnings of $2.1 per share surpassing the Zacks Consensus Estimate of $2.04 and revenues of $899.1 million exceeding expectations by 1.99%. The company has consistently beaten EPS and revenue estimates over the last four quarters. Despite the positive performance, the stock currently holds a Zacks Rank #4 (Sell) due to an unfavorable estimate revisions trend, suggesting potential underperformance in the near future.

https://finance.yahoo.com/news/idex-iex-q4-earnings-revenues-131004991.html

2 News Article Image Idex (IEX) Q4 Earnings and Revenues Beat Estimates

IEX Expects Organic Sales Increase in First Quarter

IDEX Corp (IEX) anticipates a 1% organic sales increase for Q1, driven by strong demand in its Health and Science Technologies (HST) segment, particularly due to AI-related projects. Despite challenges in other segments, the company maintains robust financial health with a strong current ratio and balanced debt-to-equity. While the stock's valuation metrics show it nearing a one-year high in P/B ratio and approaching overbought territory via RSI, analysts suggest a moderate buy.

https://www.gurufocus.com/news/8580254/iex-expects-organic-sales-increase-in-first-quarter

3 Missing News Article Image IEX Expects Organic Sales Increase in First Quarter

Idex: Overview of Fourth Quarter Financial Results

IDEX Corp. announced strong financial results for the fourth quarter, with net income reaching $128.3 million and adjusted earnings per share of $2.10, exceeding analyst predictions. The company reported $899.1 million in revenue for the quarter and $3.46 billion for the full year. Looking ahead, IDEX projects first-quarter earnings per share between $1.73 and $1.78, and full-year earnings per share between $8.15 and $8.35.

https://www.bitget.com/amp/news/detail/12560605182812

4 Missing News Article Image Idex: Overview of Fourth Quarter Financial Results

IDEX Corporation Price History

05.00.2026 - IEX Stock was up 2.0%

  • A notable surge in Harvey Investment Co. LLC's ownership in IEX, coupled with IEX's announcement of a $1.0 billion share repurchase scheme and a quarterly dividend, likely bolstered investor confidence, driving the bullish market movement.
  • Analysts' "Moderate Buy" rating and the average price target of $196.86 contributed to the positive sentiment surrounding IEX, indicating a promising outlook for the company's future performance.
  • Emphasizing IEX as a stable and growth-oriented investment choice, focusing on indispensable products, strong cash flow, and reliable dividends, may have attracted more long-term investors, elevating the stock value.
  • Overall, the combination of a substantial increase in ownership by a significant investor, favorable analyst ratings, and the depiction of IEX as a dependable option for stability and growth likely played a pivotal role in today's bullish market movement of IDEX Corporation.

30.09.2024 - IEX Stock was up 3.9%

  • IDEX Corporation (IEX) experienced a strong bullish movement today.
  • The company's Q3 earnings surpassed estimates and sales increased year over year, particularly driven by strength in the Fire & Safety/Diversified Products segment.
  • The appointment of a new Chief Financial Officer may have also contributed positively to investor sentiment.
  • Despite concerns about weaknesses in certain segments and escalating operating expenses, the overall positive earnings report and strategic appointments seem to have outweigh any potential negative impacts on the stock, leading to the bullish market movement.

11.09.2024 - IEX Stock was up 2.3%

  • A notable increase in Morten Opstad's voting rights in IDEX Biometrics could indicate a high level of confidence in the company's direction and future potential, thereby enhancing investor sentiment.
  • An extraordinary general meeting scheduled for 09 October 2024 is expected to involve significant decisions or announcements that could positively impact the company's stock price.
  • The recent disclosure of voting rights has fostered trust and transparency among investors, resulting in heightened buying interest and driving a bullish trend in IDEX's stock.

04.01.2026 - IEX Stock was up 5.2%

  • IDEX (IEX) experienced a strong uptrend today supported by its robust Q4 2025 performance and optimistic projections for 2026.
  • The company's success in the HST segment, fueled by demand from data centers and semiconductors, notably influenced the positive market movement.
  • Significant order increase in AI-related ventures, surpassing earnings and revenue forecasts, reinforced investor faith in IDEX.
  • Despite maintaining a Zacks Rank #4 (Sell) owing to adjustments in estimates, the favorable financial outcomes and outlook are likely to have eclipsed this, prompting the bullish market activity.

05.01.2025 - IEX Stock was down 7.9%

  • The positive outlook for IEX's Q4 earnings was overshadowed by broader market concerns, leading to a bearish movement in the stock.
  • Despite the anticipated strength in FMT and FSDP segments, external factors may have influenced investor sentiment and triggered the downward trend.
  • Market volatility or macroeconomic factors could have played a role in the bearish movement, despite the company's potential for growth in the upcoming earnings report.

17.08.2025 - IEX Stock was down 1.6%

  • The launch of IDEX Biometrics ASA's new product portfolio for payment and access solutions did not seem to positively impact IEX's stock price.
  • The continuous decline in IEX's stock price may be attributed to the overall downward trend the company has been experiencing since April 2024.
  • Despite the innovative advancements in biometric authentication offerings by IDEX Biometrics ASA, investors may be more focused on the overall performance and market sentiment towards IEX Corporation, leading to the bearish movement in the stock price.
  • The rising downside risk stated to have further contributed to the bearish movement in IEX's stock today.

03.03.2025 - IEX Stock was down 6.1%

  • Despite various strengths like business operations, acquisitions, and shareholder-friendly policies, concerns over escalating costs and expenses impacted the stock negatively.
  • Uncertainty arose among investors possibly due to the revelation of voting rights for the chair of IDEX Biometrics, contributing to the downward trend in the company's stock price.
  • Ongoing operational challenges and reported governance issues may have prompted investors to sell shares, exacerbating the bearish movement.

30.06.2025 - IEX Stock was down 8.1%

  • Despite surpassing Q2 earnings and revenue expectations, IDEX (IEX) saw a downward trend in the market recently.
  • The registration of a share capital increase and a partnership with Savyint Group in Vietnam likely influenced investor confidence positively.
  • However, uncertainties related to an upcoming extraordinary general meeting and the company's future plans might have led investors to secure profits, contributing to the market decline.
  • The market reaction to the Q2 earnings report and how the company performed in comparison to expectations could have also impacted the recent market movement.

29.09.2025 - IEX Stock was up 7.3%

  • IEX is expected to post Q3 earnings with solid gains in Health & Science and Fire & Safety, which could have boosted investor confidence in the company's performance.
  • Despite not meeting the specific criteria for a likely earnings beat according to market expectations, investors might be optimistic about the overall growth potential of IEX.
  • The positive sentiment surrounding IEX's diverse product offerings and potential growth in key sectors could have contributed to the bullish movement in the stock today.

30.06.2025 - IEX Stock was down 11.4%

  • Despite surpassing Q2 earnings estimates and experiencing revenue growth, the stock saw a bearish movement, indicating that the market may have had higher expectations.
  • The registration of a share capital increase could have led to dilution concerns among investors, impacting the stock price negatively.
  • The partnership with Savyint Group for next-gen access cards is a positive development, but it seems that the market sentiment was influenced more by other factors leading to the bearish movement.
  • The overall market reaction suggests that despite positive earnings and strategic partnerships, other factors such as margin slip and rising costs might have weighed on investor confidence, resulting in the bearish movement.

30.06.2025 - IEX Stock was down 6.3%

  • The registration of a share capital increase might have led to dilution concerns among investors, impacting the stock negatively.
  • Despite the partnership announcement with Savyint Group, the market may have reacted negatively due to uncertainties surrounding the implementation and success of the new technology.
  • The anticipation of IEX posting Q2 earnings could have created volatility in the stock price, with investors potentially taking profits before the release.
  • The high expectations for an earnings beat might have resulted in a "sell the news" scenario, where investors sold off shares after the earnings report, even if the results were positive.

29.09.2025 - IEX Stock was up 5.2%

  • Idex (IEX) reported better-than-expected Q3 earnings and revenue, surpassing estimates by +5.18% and +2.37% respectively.
  • The strong performance was driven by solid gains in the Health & Science and Fire & Safety segments, offsetting any softness in the Fluid & Metering segment.
  • Investors reacted positively to the news, leading to a bullish movement in the stock as the results hint at a promising future for Idex Corporation.
  • The market seems to be optimistic about Idex's ability to navigate through challenges and capitalize on opportunities in its various business segments.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.